How does methyldopa affect lipid profiles, including its impact on cholesterol and triglyceride levels and what are the implications for cardiovascular risk?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Methyldopa generally does not significantly affect lipid profiles and is unlikely to alter cholesterol or triglyceride levels, posing minimal impact on cardiovascular risk.